Arnold M. Baskies - 27 Jul 2026 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Reporting relationship: Director
Issuer ticker: ANIX
Reported as of: 27 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jul 2026, 09:14:58 UTC
Prior SEC filing: 29 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Arnold M. Baskies

Key filing fact

Arnold M. Baskies filed Form 4 for Anixa Biosciences Inc (ANIX) on 29 Jul 2026.

Key facts

This page summarizes Arnold M. Baskies's Form 4 filing for Anixa Biosciences Inc (ANIX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 Jul 2026, 09:14.

Change

Previous filing in this sequence was filed on 29 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001683567 Primary reporting owner

Baskies Arnold M

Relationship: Director
Address: C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE,
Signature: /s/ Arnold M. Baskies
Signature date: 29 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIX transaction

Common Stock

Options Exercise

Transaction value
Shares: +6,000
Change %: +4.4%
Price: $3.13^*
Shares after: 141,000
Date: 27 Jul 2026
Ownership: Direct

ANIX transaction

Common Stock

Tax liability

Transaction value
Shares: -5,428
Change %: -3.8%
Price: $3.46^*
Shares after: 135,572
Date: 27 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANIX transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -6,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,000
Exercise price: $3.13
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the "registrant") to cover the exercise price of the stock options.

Footnote F2

Right-To-Buy, pursuant to a stock option grant dated August 23, 2013.